| UniProt ID | FNTA_HUMAN | |
|---|---|---|
| UniProt AC | P49354 | |
| Protein Name | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | |
| Gene Name | FNTA | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 379 | |
| Subcellular Localization | ||
| Protein Description | Essential subunit of both the farnesyltransferase and the geranylgeranyltransferase complex. Contributes to the transfer of a farnesyl or geranylgeranyl moiety from farnesyl or geranylgeranyl diphosphate to a cysteine at the fourth position from the C-terminus of several proteins having the C-terminal sequence Cys-aliphatic-aliphatic-X. May positively regulate neuromuscular junction development downstream of MUSK via its function in RAC1 prenylation and activation.. | |
| Protein Sequence | MAATEGVGEAAQGGEPGQPAQPPPQPHPPPPQQQHKEEMAAEAGEAVASPMDDGFVSLDSPSYVLYRDRAEWADIDPVPQNDGPNPVVQIIYSDKFRDVYDYFRAVLQRDERSERAFKLTRDAIELNAANYTVWHFRRVLLKSLQKDLHEEMNYITAIIEEQPKNYQVWHHRRVLVEWLRDPSQELEFIADILNQDAKNYHAWQHRQWVIQEFKLWDNELQYVDQLLKEDVRNNSVWNQRYFVISNTTGYNDRAVLEREVQYTLEMIKLVPHNESAWNYLKGILQDRGLSKYPNLLNQLLDLQPSHSSPYLIAFLVDIYEDMLENQCDNKEDILNKALELCEILAKEKDTIRKEYWRYIGRSLQSKHSTENDSPTNVQQ | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Acetylation | ------MAATEGVGE ------CCCCCCCCH | 24.08 | 19413330 | |
| 49 | Phosphorylation | EAGEAVASPMDDGFV HHHHHCCCCCCCCCC | 17.73 | 26074081 | |
| 57 | Phosphorylation | PMDDGFVSLDSPSYV CCCCCCCCCCCCCEE | 24.97 | 28985074 | |
| 60 | Phosphorylation | DGFVSLDSPSYVLYR CCCCCCCCCCEEEEC | 22.49 | 26074081 | |
| 62 (in isoform 2) | Phosphorylation | - | 31.65 | 29116813 | |
| 62 | Phosphorylation | FVSLDSPSYVLYRDR CCCCCCCCEEEECCC | 31.65 | 26074081 | |
| 63 | Phosphorylation | VSLDSPSYVLYRDRA CCCCCCCEEEECCCC | 9.62 | 26074081 | |
| 66 | Phosphorylation | DSPSYVLYRDRAEWA CCCCEEEECCCCCCC | 10.63 | 26074081 | |
| 92 | Phosphorylation | NPVVQIIYSDKFRDV CCCEEEEECCCCHHH | 16.67 | - | |
| 93 | Phosphorylation | PVVQIIYSDKFRDVY CCEEEEECCCCHHHH | 24.74 | - | |
| 95 | Ubiquitination | VQIIYSDKFRDVYDY EEEEECCCCHHHHHH | 36.04 | - | |
| 142 | Ubiquitination | HFRRVLLKSLQKDLH HHHHHHHHHHHHHHH | 44.98 | 33845483 | |
| 152 | Sulfoxidation | QKDLHEEMNYITAII HHHHHHHHCHHHHHH | 4.14 | 30846556 | |
| 161 (in isoform 2) | Ubiquitination | - | 62.87 | 21906983 | |
| 183 | Phosphorylation | VEWLRDPSQELEFIA HHHHHCHHHHHHHHH | 40.34 | 28348404 | |
| 198 | Ubiquitination | DILNQDAKNYHAWQH HHHCCCCCHHHHHHH | 67.35 | - | |
| 228 (in isoform 1) | Ubiquitination | - | 61.53 | 21906983 | |
| 228 | Ubiquitination | QYVDQLLKEDVRNNS HHHHHHHHHHHHCCC | 61.53 | 22817900 | |
| 247 | Phosphorylation | RYFVISNTTGYNDRA EEEEEECCCCCCHHH | 18.14 | - | |
| 248 | Phosphorylation | YFVISNTTGYNDRAV EEEEECCCCCCHHHH | 41.75 | - | |
| 250 | Phosphorylation | VISNTTGYNDRAVLE EEECCCCCCHHHHHH | 16.29 | - | |
| 253 | Methylation | NTTGYNDRAVLEREV CCCCCCHHHHHHHHH | 23.98 | - | |
| 287 | Methylation | LKGILQDRGLSKYPN HHHHHHHCCHHHCCH | 34.68 | - | |
| 336 | Ubiquitination | NKEDILNKALELCEI CHHHHHHHHHHHHHH | 51.40 | 29967540 | |
| 346 | Ubiquitination | ELCEILAKEKDTIRK HHHHHHHHCCHHHHH | 62.95 | 29967540 | |
| 350 | Phosphorylation | ILAKEKDTIRKEYWR HHHHCCHHHHHHHHH | 33.48 | - | |
| 355 | Phosphorylation | KDTIRKEYWRYIGRS CHHHHHHHHHHHHHH | 9.75 | 20068231 | |
| 358 | Phosphorylation | IRKEYWRYIGRSLQS HHHHHHHHHHHHHHH | 8.12 | 20068231 | |
| 362 | Phosphorylation | YWRYIGRSLQSKHST HHHHHHHHHHHCCCC | 26.08 | 20068231 | |
| 365 | Phosphorylation | YIGRSLQSKHSTEND HHHHHHHHCCCCCCC | 37.31 | 20068231 | |
| 366 | Ubiquitination | IGRSLQSKHSTENDS HHHHHHHCCCCCCCC | 28.72 | 29967540 | |
| 368 | Phosphorylation | RSLQSKHSTENDSPT HHHHHCCCCCCCCCC | 40.95 | 30206219 | |
| 369 | Phosphorylation | SLQSKHSTENDSPTN HHHHCCCCCCCCCCC | 38.23 | 22167270 | |
| 373 | Phosphorylation | KHSTENDSPTNVQQ- CCCCCCCCCCCCCC- | 45.25 | 22167270 | |
| 375 | Phosphorylation | STENDSPTNVQQ--- CCCCCCCCCCCC--- | 52.56 | 22167270 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of FNTA_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of FNTA_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FNTA_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| TGFR1_HUMAN | TGFBR1 | physical | 8530343 | |
| TGM2_HUMAN | TGM2 | physical | 21988832 | |
| INHBB_HUMAN | INHBB | physical | 21988832 | |
| STAT2_HUMAN | STAT2 | physical | 21988832 | |
| SAFB2_HUMAN | SAFB2 | physical | 21988832 | |
| RL13A_HUMAN | RPL13A | physical | 21988832 | |
| HXK2_HUMAN | HK2 | physical | 22863883 | |
| TOP1_HUMAN | TOP1 | genetic | 28319113 | |
| KDM6A_HUMAN | KDM6A | genetic | 28319113 | |
| XRCC3_HUMAN | XRCC3 | genetic | 27453043 | |
| ATAD5_HUMAN | ATAD5 | genetic | 27453043 | |
| BLM_HUMAN | BLM | genetic | 27453043 | |
| MTOR_HUMAN | MTOR | genetic | 27453043 | |
| RS19_HUMAN | RPS19 | genetic | 27453043 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-373, AND MASS SPECTROMETRY. | |
| Phosphorylation | |
| Reference | PubMed |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGESCALE ANALYSIS] AT SER-373, AND MASS SPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-373, AND MASSSPECTROMETRY. | |